Australian Clinical Labs Limited announced that Dr. Michael Stanford AM has tendered his resignation as a non-executive director, with his resignation to take effect just prior to the conclusion of the Company's AGM on 19 October 2022. Michael had a close association with ACL prior to its IPO, having been the group CEO of St John of God Health Care for 16 years and then a non-executive director of Clinical Labs Pty Ltd. from 2016 to 2019, following its acquisition of St John of God Health Care. Since joining the Board of ACL in April 2021, Michael has acted as Chair of the Risk Committee and his medical background as a former specialist in public health medicine has made him a most valuable member of the Board.

The Company would like to take this opportunity to thank Michael for his meaningful contribution to the Board over the last 18 months. The Company wishes him all the very best as he continues to pursue his non-executive career.